Avandia

A bottle and pills of the <a class="taxInlineTagLink" id="HEDAI0000022" title="Diabetes" href="/topic/health/diseases-illnesses/diabetes-HEDAI0000022.topic">diabetes</a> drug, Avandia. The U.S. Food and Drug Administration panel voted to recommend that <a class="taxInlineTagLink" id="ORCRP006545" title="GlaxoSmithKline PLC" href="/topic/business/glaxosmithkline-plc-ORCRP006545.topic">GlaxoSmithKline PLC</a>'s (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Photo by illustration Joe Raedle/Getty Images)
sns-pod-0715-pix

A bottle and pills of the diabetes drug, Avandia. The U.S. Food and Drug Administration panel voted to recommend that GlaxoSmithKline PLC's (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Photo by illustration Joe Raedle/Getty Images)

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook
  • Home Delivery Home Delivery

PHOTO GALLERIES

TOP VIDEO

CONNECT WITH US


2013 YEAR IN REVIEW
Look for this special section in your
Baltimore Sun newspaper on Dec. 29, 2013.
  • Twitter
  • Facebook
  • Instagram
  • Google Plus
  • RSS Feeds
  • Mobile Alerts and Apps

Contact Us | Newsroom directory | Social Sun